Subscribe
shutterstock_1086968018_jarretera-2
Jarretera / Shutterstock.com
17 June 2019Americas

FDA selects Merck, IBM, KPMG and Walmart for blockchain pilot

The US Food and Drug Administration (FDA) has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.
Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
IBM patent targets blockchain in open scientific research
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.


Editor's picks

Bankruptcy judge approves $305m sale of genetics testing company
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025

Editor's picks

Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025

More on this story

Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.
Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
IBM patent targets blockchain in open scientific research
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.

More on this story

Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.
Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
IBM patent targets blockchain in open scientific research
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.

More features

Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?
Broad Institute wins appeal to restore CRISPR patent in Europe
BMS faces fresh lawsuit over alleged cancer drug monopoly
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations